MRNAModerna, Inc.
Conviction breakdown
By signal type
By stance
By conviction
By time horizon
The narratives
The presenter expresses strong optimism about MRNA due to an upcoming presentation that could provide significant updates on their cancer therapy, indicating potential for growth. The mention of a price target increase also supports a bullish outlook.
The presenter highlights MRNA's strong performance and bullish control, indicating a positive outlook.
The presenter discusses the froth in MRNA's stock price due to speculative expectations about the cancer vaccine's potential, indicating uncertainty about its actual benefits and market performance.
The presenter discusses a significant drop in Moderna's stock due to negative news regarding a cancer trial, indicating a bearish outlook.
The presenter discusses trading MRNA's volatility and mentions a bounce, indicating a bullish stance.
Summaries and classifications are generated automatically by AI and are not reviewed by hand.
Conviction history
3 of 8 days measured · shaded = no mentions
Creator coverage
First in this window: Stock Moe · Sep 30, 2026
| BInvestor's Business Daily185k subs | 4 | 44.10 | BEAR | Not stated |
| BTheChartGuys202k subs | 3 | 41.73 | BULL | <1M |
| BTraderTV Live593k subs | 3 | 32.52 | BEAR | <1M |
| AMeet Kevin2.1M subs | 2 | 29.34 | BULL | 1–6M |
| ARicky Gutierrez1.2M subs | 1 | 10.49 | BULL | <1M |
| BStock Moe720k subs | 1 | 8.47 | BEAR | <1M |